ITCI | Intra-Cellular Therapies, Inc. Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	80.83 - 84.19
52 Week Range	62.78 - 93.45
Beta	0.72
Implied Volatility	38.02%
IV Rank	16.57%
Day's Volume	691,858
Average Volume	560,888
Shares Outstanding	106,017,000
Market Cap	8,823,794,910
Sector	Healthcare
Industry	Drug Manufacturers - Specialty & Generic
IPO Date	2014-01-07

Valuation
Profitability
Growth
Health
P/E Ratio	-95.67
Forward P/E Ratio	N/A
EPS	-0.87
1YR Price Target	N/A
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	610
Country	USA
Website	ITCI

Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in developing lumateperone, which is in Phase III clinical trial for the treatment of bipolar depression, as well as to treat autism spectrum disorder; and in additional neuropsychiatric indications, such as sleep disorders associated with neuropsychiatric and neurological disorders. In addition, the company is developing Lenrispodun (ITI-214) for the treatment of Parkinson's disease and heart failure; ITI-1284-ODT-SL for the treatment of neuropsychiatric disorders and behavioral disturbances in dementia; and ITI-333 for substance use disorders, pain, and psychiatric comorbidities, including depression and anxiety. Intra-Cellular Therapies, Inc. was founded in 2002 and is headquartered in New York, New York.

ITCI's peers: ALKS, AMRX, ASRT, AVDL, COLL, CYTH, DVAX, EBS, ELAN, EOLS, ESPR, HCM, IRWD, DCPH, PCRX, EGRX, NBIX, AMPH, ANIP, AQST, KALA, OPTN, ORGO, RDY, RMTI, ZTS, ALVO

*Chart delayed

Analyzing fundamentals for ITCI we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is strong. For more detailed analysis please see ITCI Fundamentals page.

Watching at ITCI technicals we can see that long-term trend is bullish, the same as bullish middle-term trend, but short-term trend is bearish. More technicals details can be found on ITCI Technicals page.